- Rosslyn Data Technologies
- 19 June 2025 16:15:01
Source: Sharecast
In a trading update published ahead of its full-year results, the AIM-traded spend analytics firm said revenue for the 2025 financial year was expected to come in at £3.3m, up from £2.9m in the prior year.
Adjusted EBITDA losses were anticipated to narrow to £1.7m from £2.5m, in line with market expectations.
The improved performance was attributed to new development and professional services revenue, particularly linked to a major new global technology client secured in the first half.
Rosslyn said the development fees were related to bespoke integration work, while professional services income was driven by tailoring the platform to individual customer requirements.
The company ended the financial year with cash and equivalents of around £1.7m, more than doubling the £0.6m held a year earlier. Its monthly cash burn rate has fallen to £142,000 from £218,000.
Rosslyn said the improvement in EBITDA and cash flow also reflected lower operating costs, following prior-year restructuring and the closure of its Portsmouth office.
Momentum entering 2026 was described as strong, with an expanded sales pipeline and early traction, including a new three-year contract with a UK train operator worth £0.2m in total revenue.
Rosslyn said it expected further development work with its major customer and ongoing pipeline conversion to reduce cash burn further in the first half and to become cash generative on a monthly basis by the end of 2026.
The board said it was focused on sustainable growth, with a shift towards larger, higher-quality customer profiles.
While the strategy had extended some sales cycles, including additional departmental rollouts for the major client, Rosslyn said it believed it was laying the foundation for stronger long-term value creation.
“The board looks to the future with confidence,” the company said, reiterating its clear path to delivering positive and sustainable growth over the coming year.
Reporting by Josh White for Sharecast.com.